학술논문
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial
Document Type
Article
Source
In: Infectious Diseases and Therapy . (Infectious Diseases and Therapy, February 2024, 13(2):401-411)
Subject
Language
English
ISSN
21936382
21938229
21938229